Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Identification of new citrulline-specific autoantibodies, which bind to human arthritic cartilage, by mass spectrometric analysis of citrullinated type II collagen.

Haag S, Schneider N, Mason DE, Tuncel J, Andersson IE, Peters EC, Burkhardt H, Holmdahl R.

Arthritis Rheumatol. 2014 Jun;66(6):1440-9. doi: 10.1002/art.38383.

2.

Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.

Burkhardt H, Sehnert B, Bockermann R, Engström A, Kalden JR, Holmdahl R.

Eur J Immunol. 2005 May;35(5):1643-52.

3.

[T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis].

Tian X, Zhao Y, Li ZG.

Zhonghua Yi Xue Za Zhi. 2009 Mar 17;89(10):673-6. Chinese.

PMID:
19595060
4.

A Novel HLA-DRB1*10:01-Restricted T Cell Epitope From Citrullinated Type II Collagen Relevant to Rheumatoid Arthritis.

Chemin K, Pollastro S, James E, Ge C, Albrecht I, Herrath J, Gerstner C, Tandre K, Sampaio Rizzi T, Rönnblom L, Catrina A, Holmdahl R, Klareskog L, de Vries N, Malmström V.

Arthritis Rheumatol. 2016 May;68(5):1124-35. doi: 10.1002/art.39553.

5.

Characterization and Localization of Citrullinated Proteoglycan Aggrecan in Human Articular Cartilage.

Glant TT, Ocsko T, Markovics A, Szekanecz Z, Katz RS, Rauch TA, Mikecz K.

PLoS One. 2016 Mar 4;11(3):e0150784. doi: 10.1371/journal.pone.0150784. eCollection 2016.

6.

Citrullination of synovial proteins in murine models of rheumatoid arthritis.

Vossenaar ER, Nijenhuis S, Helsen MM, van der Heijden A, Senshu T, van den Berg WB, van Venrooij WJ, Joosten LA.

Arthritis Rheum. 2003 Sep;48(9):2489-500.

7.

Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles.

van Beers JJ, Willemze A, Stammen-Vogelzangs J, Drijfhout JW, Toes RE, Pruijn GJ.

Arthritis Res Ther. 2012 Feb 17;14(1):R35. doi: 10.1186/ar3744.

8.

Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice.

Lindh I, Snir O, Lönnblom E, Uysal H, Andersson I, Nandakumar KS, Vierboom M, 't Hart B, Malmström V, Holmdahl R.

Arthritis Res Ther. 2014 Jul 8;16(4):R143. doi: 10.1186/ar4605.

9.

Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.

Burkhardt H, Koller T, Engström A, Nandakumar KS, Turnay J, Kraetsch HG, Kalden JR, Holmdahl R.

Arthritis Rheum. 2002 Sep;46(9):2339-48.

10.

Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity.

Lundberg K, Nijenhuis S, Vossenaar ER, Palmblad K, van Venrooij WJ, Klareskog L, Zendman AJ, Harris HE.

Arthritis Res Ther. 2005;7(3):R458-67. Epub 2005 Feb 21.

11.

[Significance of citrullinated collagen type II and its antibodies in rheumatoid arthritis].

Tian X, Bi LQ, Li ZG.

Zhonghua Yi Xue Za Zhi. 2006 Sep 5;86(33):2334-8. Chinese.

PMID:
17156630
12.

Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.

Shoda H, Fujio K, Shibuya M, Okamura T, Sumitomo S, Okamoto A, Sawada T, Yamamoto K.

Arthritis Res Ther. 2011;13(6):R191. doi: 10.1186/ar3520. Epub 2011 Nov 22.

13.

Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.

Wegner N, Lundberg K, Kinloch A, Fisher B, Malmström V, Feldmann M, Venables PJ.

Immunol Rev. 2010 Jan;233(1):34-54. doi: 10.1111/j.0105-2896.2009.00850.x. Review.

PMID:
20192991
14.

Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps.

Pratesi F, Dioni I, Tommasi C, Alcaro MC, Paolini I, Barbetti F, Boscaro F, Panza F, Puxeddu I, Rovero P, Migliorini P.

Ann Rheum Dis. 2014 Jul;73(7):1414-22. doi: 10.1136/annrheumdis-2012-202765. Epub 2013 Jun 1.

PMID:
23727635
15.

Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.

Ossipova E, Cerqueira CF, Reed E, Kharlamova N, Israelsson L, Holmdahl R, Nandakumar KS, Engström M, Harre U, Schett G, Catrina AI, Malmström V, Sommarin Y, Klareskog L, Jakobsson PJ, Lundberg K.

Arthritis Res Ther. 2014 Aug 12;16(4):R167. doi: 10.1186/ar4683.

16.

Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen.

Auger I, Martin M, Balandraud N, Roudier J.

Arthritis Rheum. 2010 Jan;62(1):126-31. doi: 10.1002/art.27230.

17.

Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.

Markovics A, Ocskó T, Katz RS, Buzás EI, Glant TT, Mikecz K.

PLoS One. 2016 Jul 28;11(7):e0160284. doi: 10.1371/journal.pone.0160284. eCollection 2016.

18.

Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.

Goules JD, Goules AV, Tzioufas AG.

Clin Exp Immunol. 2013 Oct;174(1):10-7. doi: 10.1111/cei.12145.

19.

Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.

Schwenzer A, Jiang X, Mikuls TR, Payne JB, Sayles HR, Quirke AM, Kessler BM, Fischer R, Venables PJ, Lundberg K, Midwood KS.

Ann Rheum Dis. 2016 Oct;75(10):1876-83. doi: 10.1136/annrheumdis-2015-208495. Epub 2015 Dec 9.

20.

Recognition of new citrulline-containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of rheumatoid arthritis patients.

Szarka E, Babos F, Magyar A, Huber K, Szittner Z, Papp K, Prechl J, Pozsgay J, Neer Z, Ádori M, Nagy G, Rojkovich B, Gáti T, Kelemen J, Baka Z, Brózik M, Pazár B, Poór G, Hudecz F, Sármay G.

Immunology. 2014 Feb;141(2):181-91. doi: 10.1111/imm.12175.

Supplemental Content

Support Center